German Chancellor Olaf Scholz announced an agreement on Friday to let expatriates in China use the COVID-19 vaccine from Germany’s BioNTech and pressed for Beijing to allow the shot to be made freely available to Chinese citizens.
https://www.pharmalive.com/wp-content/uploads/2021/04/BioNTech-expects-vaccine-trial-results-for-babies-by-September-Reuters-4-29-21.jpg503960Reuters Healthhttps://www.pharmalive.com/wp-content/uploads/2020/01/Pharmalive_4c-300x37.pngReuters Health2022-11-04 06:28:412022-11-04 08:58:40Scholz secures agreement allowing expats in China to use BioNTech COVID-19 vaccine
